Sort
3,198 grants matching “mrna vaccine”
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$879,161Beatrice H Hahn · University Of Pennsylvania · R37 · FY2024 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$878,617John Ross Teijaro · Scripps Research Institute, The · R01 · FY2023 · AI
RNA: New Antimicrobial Strategies
$877,860Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses
$874,358Parham Ramezani-Rad · La Jolla Institute For Immunology · R61 · FY2025 · AI
COVID-19 Sample Collection and Vaccine Studies
$873,600Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization
$873,050Leonidas A Stamatatos · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Small Molecule Inhibitors of Ebola Virus Polymerase Function
$872,936Christopher F Basler · Georgia State University · R01 · FY2018 · AI
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$871,042Barton F Haynes · Duke University · U19 · FY2020 · AI
Function of granulysin
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Posttranscriptional control of gene expression
$867,531Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
An Env apex-focused HIV-1 vaccine strategy
$867,099Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$866,441Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$865,682Charles Bix Shoemaker · Tufts University Boston · R01 · FY2023 · AI
" Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons.â
$865,387Gaurav Das Gaiha · Massachusetts General Hospital · R01 · FY2025 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$865,153Beatrice H Hahn · University Of Pennsylvania · R37 · FY2025 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$863,551John Ross Teijaro · Scripps Research Institute, The · R01 · FY2025 · AI
A new humanized mouse model to study HBV gene editing
$862,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$860,928Beatrice H Hahn · University Of Pennsylvania · R37 · FY2020 · AI
Nucleoside modified mRNA based HIV vaccine
$859,974Drew Weissman · University Of Pennsylvania · R01 · FY2016 · AI
Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by ChAd and mRNA
$859,455Gaurav Das Gaiha · Massachusetts General Hospital · R01 · FY2024 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$858,966Beatrice H Hahn · University Of Pennsylvania · R37 · FY2021 · AI
Diet and Duration of Cervical HPV Infection
$857,678Marc T Goodman · University Of Hawaii At Manoa · R01 · FY2009 · CA
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
$856,238Scott G Hansen · Oregon Health & Science University · R01 · FY2017 · AI
COVID-19 vaccine in naive individuals and cancer patients
$851,991Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$850,811David Sacks · Niaid Extramural Activities · Z01 · FY2007 · AI